289 related articles for article (PubMed ID: 20216330)
41. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
42. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
Pamuk ON; Akbay FG; Dönmez S; Yilmaz N; Calayir GB; Yavuz S
Lupus; 2013 Nov; 22(13):1416-24. PubMed ID: 23929639
[TBL] [Abstract][Full Text] [Related]
43. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
44. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Akawatcharangura P; Taechakraichana N; Osiri M
Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
[TBL] [Abstract][Full Text] [Related]
46. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
Nossent JC
J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
[TBL] [Abstract][Full Text] [Related]
47. Herpes zoster in patients with systemic lupus erythematosus.
Moutsopoulos HM; Gallagher JD; Decker JL; Steinberg AD
Arthritis Rheum; 1978; 21(7):798-802. PubMed ID: 697950
[TBL] [Abstract][Full Text] [Related]
48. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
Uramoto KM; Michet CJ; Thumboo J; Sunku J; O'Fallon WM; Gabriel SE
Arthritis Rheum; 1999 Jan; 42(1):46-50. PubMed ID: 9920013
[TBL] [Abstract][Full Text] [Related]
49. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
Lalani S; Pope J; de Leon F; Peschken C;
J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
[TBL] [Abstract][Full Text] [Related]
50. Necrotizing fasciitis in systemic lupus erythematosus.
Kamran M; Wachs J; Putterman C
Semin Arthritis Rheum; 2008 Feb; 37(4):236-42. PubMed ID: 17570472
[TBL] [Abstract][Full Text] [Related]
51. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
52. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
Silva MF; Ferriani MP; Terreri MT; Pereira RM; Magalhães CS; Bonfá E; Campos LM; Okuda EM; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
[TBL] [Abstract][Full Text] [Related]
53. The characteristics of systemic lupus erythematosus. A study in a general hospital.
Karadsheh MF; Nimri FA; Ajlouni YM; Dneibat WA; Karadsheh RF
Saudi Med J; 2000 Mar; 21(3):282-6. PubMed ID: 11533799
[TBL] [Abstract][Full Text] [Related]
54. Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort.
Ribeiro FM; Leite MA; Velarde GC; Fabris CL; Santos RC; Lugon JR
Am J Nephrol; 2005; 25(6):596-603. PubMed ID: 16282677
[TBL] [Abstract][Full Text] [Related]
55. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus.
Mok MY; Ip WK; Lau CS; Lo Y; Wong WH; Lau YL
J Rheumatol; 2007 Jun; 34(6):1270-6. PubMed ID: 17552055
[TBL] [Abstract][Full Text] [Related]
56. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
[TBL] [Abstract][Full Text] [Related]
57. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
58. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
[TBL] [Abstract][Full Text] [Related]
59. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus.
Ng WL; Chu CM; Wu AK; Cheng VC; Yuen KY
QJM; 2006 Jan; 99(1):37-47. PubMed ID: 16371405
[TBL] [Abstract][Full Text] [Related]
60. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
Aljohani R; Gladman DD; Su J; Urowitz MB
Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
